https://www.selleckchem.com/pr....oducts/trastuzumab-e
In the posttraining cohort, 30 cases (12.0%) were diagnosed as malignant by cytology of which 27 were detected by hematology. Of the 18 discrepant cases (all carcinomas), hematology slide review showed definite features of malignancy in 15 and no tumor cells in 3. The malignancy detection rate by the hematology laboratory significantly improved after training (68.8% versus 90.0%, P = .01). Conclusions.— We demonstrate the comparatively lower malignancy detection rate for body fluid specimens processed in our hematol
Gefällt mir
Kommentar
Teilen
